Eukaryotic translation initiation factor 4A1 pseudogene 13 (EIF4A1P13)

Eukaryotic translation initiation factor 4A1 pseudogene 13 (EIF4A1P13) is a pseudogene, meaning it is a genomic DNA sequence similar to the functional EIF4A1 gene but typically non-protein coding and non-functional[4]. Pseudogenes, by definition, lack biological activity, are not considered drug targets, and do not participate in known cellular processes or disease mechanisms. The functional homologue, EIF4A1 (eukaryaryotic translation initiation factor 4A1), is an ATP-dependent RNA helicase essential for mRNA translation initiation, but EIF4A1P13 does not share these properties[5][7]. There are no known aliases, biomarkers, drugs, or clinical roles associated with EIF4A1P13. No safety concerns or therapeutic challenges are relevant due to its absence of function. If you intended to inquire about the functional gene EIF4A1, refer instead to "Eukaryotic translation initiation factor 4A1", abbreviated as EIF4A1, which is a validated enzyme and therapeutic target in multiple disease contexts[5][7].

Other names

EIF4A1P13